Orientia tsutsugamushi
Orientia tsutsugamushi is a mite-borne bacterium that is the causative agent of scrub typhus, a disease prevalent in the Asia-Pacific region. This bacterium is transmitted to humans through the bite of infected chiggers, the larval stage of a certain type of mite.
Taxonomy[edit]
The bacterium belongs to the genus Orientia, which is part of the family Rickettsiaceae. The species name tsutsugamushi is derived from the Japanese words "tsutsuga" meaning "illness" and "mushi" meaning "insect", reflecting the disease's transmission through insect bites.
Morphology[edit]
Orientia tsutsugamushi is a small, rod-shaped, obligate intracellular bacterium. It has a unique cell wall structure that is different from other bacteria, which contributes to its ability to evade the host's immune response.
Pathogenesis[edit]
The bacterium is transmitted to humans through the bite of an infected chigger. Once inside the host, Orientia tsutsugamushi infects endothelial cells and macrophages, leading to vasculitis and multi-organ dysfunction.
Clinical Manifestations[edit]
The primary symptom of scrub typhus is a fever, which is often accompanied by headache, muscle pain, and a rash. In severe cases, complications such as pneumonia, meningitis, and myocarditis can occur.
Diagnosis and Treatment[edit]
Diagnosis of scrub typhus is typically based on clinical symptoms and confirmed by serological tests. The standard treatment is with the antibiotic doxycycline.
Prevention[edit]
Prevention strategies include avoiding areas where chiggers are prevalent and using insect repellents. There is currently no vaccine available for scrub typhus.
See Also[edit]
-
Orientia tsutsugamushi
-
O. tsutsugamushi in U937 cells
-
O. tsutsugamushi genomes
-
Trombicula larva stylostome
-
Orientia cell invasion
-
Tsutsugamushi Triangle
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian